• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常规实践中功能性肠病的管理:热点话题的专家意见综述。

Functional Bowel Disorder Management in Routine Practice with Tips for Hot Topics: Expert Opinion Review.

机构信息

Department of Gastroenterology, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye.

Department of Gastroenterology, Kocaeli University Faculty of Medicine, Kocaeli, Türkiye.

出版信息

Turk J Gastroenterol. 2024 Jun;35(6):423-439. doi: 10.5152/tjg.2024.24029.

DOI:10.5152/tjg.2024.24029
PMID:39128123
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11232060/
Abstract

Functional gastrointestinal system disorders are common problems in practice. The most common symptoms are abdominal pain, gas, bloating, diarrhea, constipation, and a mixture of these, and similar symptoms can be seen in conditions such as inflammatory bowel disease, colorectal cancer, and celiac disease depending on the age of the patient, indicating the importance of differential diagnosis. The importance of patient management is shown by making a symptom-based diagnosis and making cost-effective, that is, limited advanced examinations. The pathophysiology of irritable bowel syndrome (IBS) is multifactorial, and stress is one of the leading triggers of IBS symptoms. Therefore, terminology will change to gut-brain interaction disorders in the future, and the patient-physician relationship has a special place in the treatment of functional bowel disorder. Dietary recommendation and medical treatment in IBS should be determined according to the predominant symptom and symptom severity. In addition to diet, some lifestyle changes can also be helpful in reducing IBS symptoms. Antispasmodics and antidepressants are not fast-acting. These drugs should be used for at least 2-4 weeks to see the efficacy of treatment. Drugs should be used according to the standard recommended duration and dose in intermittent treatments.

摘要

功能性胃肠系统疾病在临床上较为常见。最常见的症状为腹痛、气胀、腹胀、腹泻、便秘,以及这些症状的混合,而类似的症状也可见于炎症性肠病、结直肠癌和乳糜泻等疾病,具体取决于患者的年龄,这表明鉴别诊断很重要。根据症状做出诊断并进行具有成本效益的、即有限的先进检查,对患者管理很重要。肠易激综合征(IBS)的病理生理学是多因素的,压力是 IBS 症状的主要诱因之一。因此,在未来术语将更改为肠-脑相互作用障碍,医患关系在功能性肠病的治疗中具有特殊地位。IBS 的饮食建议和医学治疗应根据主要症状和症状严重程度来确定。除了饮食,一些生活方式的改变也有助于减轻 IBS 症状。抗痉挛药和抗抑郁药不是快速起效的药物。这些药物应至少使用 2-4 周才能看到治疗效果。药物应根据间歇治疗中标准推荐的持续时间和剂量使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1552/11232060/df9ea33ec535/tjg-35-6-423_f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1552/11232060/0639219f5a83/tjg-35-6-423_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1552/11232060/d5a03d122801/tjg-35-6-423_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1552/11232060/b536983f28da/tjg-35-6-423_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1552/11232060/df9ea33ec535/tjg-35-6-423_f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1552/11232060/0639219f5a83/tjg-35-6-423_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1552/11232060/d5a03d122801/tjg-35-6-423_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1552/11232060/b536983f28da/tjg-35-6-423_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1552/11232060/df9ea33ec535/tjg-35-6-423_f004.jpg

相似文献

1
Functional Bowel Disorder Management in Routine Practice with Tips for Hot Topics: Expert Opinion Review.常规实践中功能性肠病的管理:热点话题的专家意见综述。
Turk J Gastroenterol. 2024 Jun;35(6):423-439. doi: 10.5152/tjg.2024.24029.
2
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.用于治疗肠易激综合征的容积性泻剂、抗痉挛药和抗抑郁药。
Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD003460. doi: 10.1002/14651858.CD003460.pub3.
3
[Pain therapy in irritable bowel syndrome].[肠易激综合征的疼痛治疗]
Schmerz. 2014 Jun;28(3):289-93. doi: 10.1007/s00482-014-1406-6.
4
Diagnosis and Treatment of Irritable Bowel Syndrome: A Review.肠易激综合征的诊断与治疗:综述
JAMA. 2021 Mar 2;325(9):865-877. doi: 10.1001/jama.2020.22532.
5
[Guidelines for the treatment of irritable bowel syndrome].[肠易激综合征治疗指南]
Korean J Gastroenterol. 2011 Feb;57(2):82-99. doi: 10.4166/kjg.2011.57.2.82.
6
Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.粪便潴留:功能性肠病、阑尾炎和痔疮的常见病因——兼论内科及外科治疗
Dan Med J. 2015 Mar;62(3).
7
Treatment of irritable bowel syndrome.肠易激综合征的治疗。
J Clin Pharm Ther. 2011 Jun;36(3):275-82. doi: 10.1111/j.1365-2710.2010.01177.x. Epub 2010 Aug 24.
8
Irritable bowel syndrome: a clinical review.肠易激综合征:临床综述。
JAMA. 2015 Mar 3;313(9):949-58. doi: 10.1001/jama.2015.0954.
9
Diagnosis and treatment of irritable bowel syndrome: state of the art.肠易激综合征的诊断与治疗:最新进展
Curr Gastroenterol Rep. 2005 Aug;7(4):249-56. doi: 10.1007/s11894-005-0016-y.
10
Common gastrointestinal symptoms: irritable bowel syndrome.常见胃肠道症状:肠易激综合征。
FP Essent. 2013 Oct;413:16-23.

引用本文的文献

1
The effect of adding pancreatin to standard otilinium bromide and simethicone treatment in type 2 diabetes mellitus patients with irritable bowel syndrome.加用胰酶对 2 型糖尿病合并肠易激综合征患者奥替溴铵和二甲硅油标准治疗的影响。
Sci Rep. 2024 Oct 21;14(1):24661. doi: 10.1038/s41598-024-74694-w.

本文引用的文献

1
Abdominophrenic Dyssynergia: A Narrative Review.腹膈协同失调症:一个叙事性综述。
Am J Gastroenterol. 2023 Jan 1;118(1):41-45. doi: 10.14309/ajg.0000000000002044. Epub 2022 Sep 30.
2
AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review.美国胃肠病学会关于饮食在肠易激综合征中作用的临床实践更新:专家综述。
Gastroenterology. 2022 May;162(6):1737-1745.e5. doi: 10.1053/j.gastro.2021.12.248. Epub 2022 Mar 23.
3
Management of bloating.腹胀的管理
Neurogastroenterol Motil. 2022 Mar;34(3):e14333. doi: 10.1111/nmo.14333. Epub 2022 Feb 10.
4
A Pragmatic Approach to the Evaluation and Treatment of Abdominal Bloating.一种评估和治疗腹胀的实用方法。
Am J Gastroenterol. 2022 May 1;117(5):701-705. doi: 10.14309/ajg.0000000000001665. Epub 2022 Jan 29.
5
Efficacy of pinaverium bromide in the treatment of irritable bowel syndrome: a systematic review and meta-analysis.匹维溴铵治疗肠易激综合征的疗效:一项系统评价与荟萃分析。
Therap Adv Gastroenterol. 2021 Sep 15;14:17562848211033740. doi: 10.1177/17562848211033740. eCollection 2021.
6
Best management of irritable bowel syndrome.肠易激综合征的最佳管理
Frontline Gastroenterol. 2020 May 28;12(4):303-315. doi: 10.1136/flgastro-2019-101298. eCollection 2021.
7
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome.英国胃肠病学会关于肠易激综合征管理的指南。
Gut. 2021 Jul;70(7):1214-1240. doi: 10.1136/gutjnl-2021-324598. Epub 2021 Apr 26.
8
What is the optimal FODMAP threshold in IBS?肠易激综合征中最佳的可发酵寡糖、双糖、单糖和多元醇阈值是多少?
J Gastroenterol Hepatol. 2021 Jun;36(6):1723-1725. doi: 10.1111/jgh.15470. Epub 2021 Feb 28.
9
Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial.低可发酵寡糖、双糖、单糖和多元醇饮食用于腹泻型肠易激综合征患者:一项前瞻性随机试验。
J Gastroenterol Hepatol. 2021 Aug;36(8):2107-2115. doi: 10.1111/jgh.15410. Epub 2021 Feb 4.
10
ACG Clinical Guideline: Management of Irritable Bowel Syndrome.ACG 临床指南:肠易激综合征的管理。
Am J Gastroenterol. 2021 Jan 1;116(1):17-44. doi: 10.14309/ajg.0000000000001036.